Cefdaloxim

Cefdaloxime is an orally active cephalosporin and HR-916 ester metabolite. Cefdaloxime has a broad spectrum of activity against pathogens such as the majority of members of the family Enterobacteriaceae, staphylococci, Streptococcus spp., Neisseria gonorrhoeae, Moraxella catarrhalis, Haemophilus influenzae[1].

80195-36-4

12352005

Bacterial; Drug Metabolite

Anti-infection; Metabolic Enzyme/Protease

Infection

OC(C1=C(COC)CS[C@@]([C@@H]2NC(/C(C3=CSC(N)=N3)=N\O)=O)([H])N1C2=O)=O

C14H15N5O6S2

413.43

[1]Jones RN, et al. Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin. J Clin Microbiol. 1992 May;30 (5) :1297-300.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-W744633/

Reference compound1

No Development Reported